Present and Future of IBSA Farmaceutici on Chemistry Today
Luca Crippa’s Interview
The visionary leadership of the Founder Arturo Licenziati allowed IBSA to transform itself, from a small Swiss laboratory in the 1940s, into a top-level global company for the pharmaceutical field. Thanks to its industrial capacity and proprietary technologies, IBSA exports scientific know-how and the “Made in Italy” excellence in the world.
82 patent families,10 therapeutic areas and more than 1600 employees are just some of the numbers that testify to the great commitment of the Company over the years.
Luca Crippa – CEO & Managing Director of IBSA Farmaceutici – told Chemistry Today that the Company, despite the pandemic, has confirmed an investment plan of € 15 million aimed at technological implementation, production expansion and the development of sustainable solutions supporting the Health System.
Among the challenges of IBSA Farmaceutici, there is the development of new products and technologies in four main areas – Fertility, Endocrinology, Osteoarticular and Aesthetic Medicine – and the search for new international partners for the production and distribution of its products.
Infact, the CPhI Worldwide, which after fourteen years returns to Italy, is an important event to share the global vision and the competitive capacity in a context of excellence such as that of the Lombard pharmaceutical industry, the first region for industrial presence with over 100 companies, 24,000 direct employees and over 28,000 in related fields.
